The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.
READING, Pa. - The YMCA of Reading & Berks County announced the completion of renovations at one of its residential living spaces. Officials say the upgrades were made at the Reading branch in the 600 ...